A group of Medicare advisors generally supported maintaining procedure-volume requirements for physicians and hospitals as a basis for covering transcatheter aortic valve replacement (TAVR) procedures during a July 25 meeting. But some in the medical and device-maker community argued that the emphasis must shift away from volume and toward quality measures.
The pros and cons of requiring physicians and hospitals to meet minimum annual procedure volumes to receive Medicare reimbursement for...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?